NeoImmuneTech (XKRX:950220) Accumulated Depreciation : ₩-7,061.35 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is NeoImmuneTech Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

NeoImmuneTech's quarterly accumulated depreciation increased from Jun. 2023 (₩-5,733.19 Mil) to Sep. 2023 (₩-6,520.25 Mil) and increased from Sep. 2023 (₩-6,520.25 Mil) to Dec. 2023 (₩-7,061.35 Mil).

NeoImmuneTech's annual accumulated depreciation increased from Dec. 2021 (₩-2,190.60 Mil) to Dec. 2022 (₩-4,353.42 Mil) and increased from Dec. 2022 (₩-4,353.42 Mil) to Dec. 2023 (₩-7,061.35 Mil).

NeoImmuneTech Accumulated Depreciation Historical Data

The historical data trend for NeoImmuneTech's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoImmuneTech Accumulated Depreciation Chart

NeoImmuneTech Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

-360.94

-927.97

-2,190.60

-4,353.42

-7,061.35

NeoImmuneTech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accumulated Depreciation	Get a 7-Day Free Trial											-4,353.42	-2,396.28	-5,733.19	-6,520.25	-7,061.35

NeoImmuneTech Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

NeoImmuneTech Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of NeoImmuneTech's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

NeoImmuneTech (XKRX:950220) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeoImmuneTech Inc (XKRX:950220) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

N/A

Address

2400 Research Boulevard, Suite 250, Rockville, MD, USA, 20850

Website

http://www.neoimmunetech.com

NeoImmuneTech Inc is a clinical-stage T cell-focused biotech company dedicated to the discovery and development of novel immuno-therapeutics. Its lead asset NT-I7 is the clinical stage IL-7, which enhances the body's immune function to address key resistance mechanisms in Immuno-Oncology and deadly infectious diseases.

NeoImmuneTech (XKRX:950220) Headlines

No Headlines